Peter Fey

4 Patents

• US122028052025

  Process for Preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic Acid and Its Crystalline Forms for Use as Pharmaceutically Active Compound

  Bayer Pharma Aktiengesellschaft

  0 cites
• US121729962024

  Methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate Active Compound Product Having Improved Properties, Production and Formulation Thereof

  Adverio Pharma GmbH

  0 cites
• US121382562024

  Treatment of Cardiopulmonary Disorders

  Bayer Pharma Aktiengesellschaft

  0 cites
• US117607372023

  Process for Manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine

  ADVERIO PHARM GmbH

  0 cites